Market Closed:
United Pharmaceuticals International, Ltd. is a holding company formed for identifying, targeting and acquiring specialty pharmaceutical distribution companies both in the United States and Europe. United has entered into an agreement to acquire 100% of the Membership Interest of Gulf Coast Pharmaceuticals Pus, LLC (“Gulf Coast”), a Mississippi United States based company.
Gulf Coast, a pharmaceutical distribution company operating since 2008, identifies scarce drugs and sources a wide variety of drugs, medical devices and ostomy supplies for resale. Gulf Coast specializes in sourcing products that are in scarce supply from a broad base of over 25,000 different dugs including antibiotics, antivirals, diabetes treatments, respiratory medicines, infusion compounds, ophthalmic preparations, glucocorticoids and unit dose solutions.
The information contained in these pages has been obtained from sources which The Bermuda Stock Exchange believes are reliable. However, the accuracy of the information cannot and is not guaranteed and The Bermuda Stock Exchange makes no representation as to its accuracy or completeness. Neither this Web site, nor any information contained herein, constitutes advice or a solicitation to subscribe, purchase or sell any securities. The Bermuda Stock Exchange expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon any part of the contents of this site or any external sites referenced from this website.
Copyright © 2019 by the Bermuda Stock Exchange. All rights reserved! Any questions or requests for information should be referred to info@bsx.com.